Omeros Corp (OMER) stock is tumbling on Friday morning following a major regulatory setback in Europe that has caught investors off guard.Investors are bailing on OMER mostly because the European Medicines Agency’s (EMA) expert panel has rejected its primary commercial asset.At the time of writing, Omeros stock is down some…
Moderna Inc. (MRNA) shares surged nearly 10% on Friday, extending a powerful rally that has lifted the stock about…
Apple Inc. (AAPL) shares have come under pressure after the company raised prices on several MacBook and iPad models.…
The Dow Jones Industrial Average and the broader US stock market closed lower on Friday as investors continued rotating…
The artificial intelligence boom has long been pitched as a transformative force that would boost productivity and eventually lower…
A growing chorus of China’s most influential hedge fund managers is sounding the alarm on what they describe as…
Asian technology stocks fell sharply on Friday, as SoftBank Group tumbled more than 12% and chip-heavy markets from Tokyo…
The Kospi Index tumbled by over 9% today, June 26, erasing most of the gains made earlier during the…